Infantile obesity: A situation of atherothrombotic risk?

Metabolism: Clinical and Experimental

Volumn 49, Issue 5, 2000, Pages 672-675

  Valle, Miguel ^a,b,c   Gascon, Félix ^a,b,c   Martos, Rosario ^a,b,c   Ruz, F Javier ^a,b,c   Bermudo, Francisco ^a,b,c   Rios, Rafael ^a,b,c   Canete, Ramón ^a,b,c  

^a Valle de los Pedroches Hospital   (Spain)

^b Basic Health Zones of Palma del Río and Hinojosa del Duque   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT DISEASE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 0034078751     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)80047-5     Document Type: Article

References (45)

1. Hubert HB Feinleib M McNamara PM Obesity as independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
2. Larsson B Svardsudd K Welin L Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: A 13-year follow-up of participants in the Study of Men Born in 1913 Br Med J 288 1984 1401 1404
3. Eckel RH Kraus RM American Heart Association call to action: Obesity as a major risk factor for coronary heart disease Circulation 97 1998 2099 2100
4. Reaven G Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
5. Ferrannini E Haffner SM Mitchell BD Hyperinsulinemia: The key feature of cardiovascular and metabolic syndrome Diabetologia 34 1991 416 422
6. Vague P Juhan-Vague I Aillaud MF Correlation between blood fibrinolytic activity, plasminogen inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects Metabolism 35 1986 250 253
7. Folsom AR Wu KK Davis CE Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors Atherosclerosis 91 1991 191 205
8. Yarnell JW Baker IA Sweetnam PM Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease Circulation 83 1991 836 844
9. Thompson SG Kienast J Pyke SDM Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris N Engl J Med 332 1995 635 641
10. Francis RB Kawanishi D Baruchi T Impaired fibrinolysis in coronary artery disease Am Heart J 115 1988 776 780
11. Alessi MC Peiretti F Morange P Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860 867
12. Lundgren CH Brown SL Nordt TK Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease Circulation 93 1996 106 110
13. Juhan-Vague I Roul C Ardissone JP Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients. Relation with plasma insulin Thromb Haemost 61 1989 370 373
14. Juhan-Vague I Alessi MC Joly P Plasma plasminogen activator inhibitor 1 in angina pectoris. Influence of plasma insulin and acute phase response Arteriosclerosis 9 1989 362 367
15. Juhan-Vague I Alessi MC Vague P Increased plasma plasminogen activator inhibitor 1 levels: A possible link between insulin resistance and atherothrombosis Diabetologia 34 1991 457 462
16. Scheneider DJ Nordt TK Sobel BE Attenuated fibrinolysis and accelerated atherosclerosis in type II diabetic patients Diabetes 42 1993 1 7
17. Tanner JM Growth and Adolescence ed 2 1962 Blackwell New York, NY
18. Garsi Hernández M Castell J Narvaiza JL Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo 1988 Fundación Fanstino Orbegozo Oxford, UK
19. Ferguson MA Gutin B Owens S Effects of physical training and its cessation on the hemostatic system of obese children Am J Clin Nutr 69 1999 1130 1134
20. Bablok W Haeckel R Meyers W Biometrical methods Haeckel R Evaluation Methods in Laboratory Medicine 1993 VCH Publishers Madrid, Spain 203 242
21. Modan M Halkin H Almong S Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance J Clin Invest 75 1985 809 818
22. DeFronzo RA Ferrannini E The pathogenesis of non-insulin dependent diabetes: An update Medicine (Baltimore) 61 1982 125 140
23. Kasim-Karakas SE Dietary fat controversy: Is it applicable to children? Am J Clin Nutr 67 1998 1106 1107
24. Taitz LS Obesity DS McLaren Burman D Belton N Williams AF ed 3 Text-Book of Paediatric Nutrition 1991 Churchill Livingstone New York, NY 485 509
25. Avellone G DiGarbo V Cordova R Evaluation of cardiovascular risk factors in overweight and obese subjects Int Angiol 13 1993 25 29
26. Juhan-Vague I Vague P Alessi MC Relationship between insulin, triglycerides, body mass index and plasminogen activator inhibitor 1 Diabete Metab 13 1987 331 336
27. Landin K Tengbom L Chmielewska J The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in men Thromb Haemost 65 1991 130 133
28. Vague P Juhan-Vague I Chabert V Fat distribution and plasminogen activator inhibitor activity in non diabetic obese women Metabolism 38 1989 913 915
29. Landin K Stigendal L Eriksson E Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor- 1 Metabolism 39 1990 1044 1048
30. Eliasson M Evrin PE Lundblad D Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: The Northern Sweden MONICA Study J Clin Epidemiol 47 1994 513 524
31. Alessi MC Juhan-Vague I Kooistra T Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatoceltular cell Hep G2 Thromb Haemost 60 1988 491 494
32. Kooistra T Bosma PJ Tons HAM Plasminogen activator inhibitor 1: Biosynthesis and mRNA levels are increased by insulin in cultured human hepatocytes Thromb Haemost 62 1989 723 728
33. Scheneider DJ Sobel BE Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: Implications for vascular disease by hyperinsulinemic states Proc Natl Acad Sci USA 88 1991 9959 9963
34. Potter Van Loon BJ de Bart ACW Radder JK Acute exogenous hyperinsulinemia does not result in elevation of plasma plasminogen activator inhibitor 1 concentration in humans Fibrinolysis 4 1990 93 94
35. Meade TW Ruddock V Stirling Y Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079
36. Meade TW Cooper JA Chakrabarti R Fibrinolytic activity and clotting factors in ischaemic heart disease in women BMJ 24 1996 1581
37. (suppl) De Pergola G De Mitrio V Giorgino F Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: Relationship with body fat distribution Diabet Med 13 1996 S16 S18
38. Chandler WL Trimble SL Loo SC Effect of PAI-1 levels on the molar concentrations of active tissue plasminogen activator (t-PA) and t-PA/PAI-1 complex in plasma Blood 76 1990 930 937
39. Meade TW Howarth DJ Cooper J Fibrinolytic activity and arterial disease Lancet 343 1994 1442
40. Theroux P Latour JG Leger-Gauthier C Fibrinopeptide A and platelet factor levels in unstable angina pectoris Circulation 75 1987 156 162
41. Kruskal JB Commerford PJ Franks JJ Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease N Engl J Med 317 1987 1361 1365
42. Aronson DL Stevan L Ball AP Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma J Clin Invest 60 1977 1410 1418
43. Ceriello A Pirisi M Giacomello R Fibrinogen plasma levels as a marker of thrombin activation: New insights on the role of fibrinogen as a cardiovascular risk factor Thromb Haemost 71 1994 593 595
44. Kannel WB Wolf PA Castelli WP Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 258 1987 1183 1186
45. Wilhelmsen L Svardsudd K Korsan-Bengtsen K Fibrinogen as a risk factor for stroke and myocardial infarction N Engl J Med 311 1984 501 505